Global Choroidal Neovascularization Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Choroidal Neovascularization market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Choroidal Neovascularization industry chain, the market status of Extreme Myopia (Intravenous, Intravitreal), Malignant Myopic Degeneration (Intravenous, Intravitreal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Choroidal Neovascularization.
Regionally, the report analyzes the Choroidal Neovascularization markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Choroidal Neovascularization market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Choroidal Neovascularization market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Choroidal Neovascularization industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Intravenous, Intravitreal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Choroidal Neovascularization market.
Regional Analysis: The report involves examining the Choroidal Neovascularization market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Choroidal Neovascularization market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Choroidal Neovascularization:
Company Analysis: Report covers individual Choroidal Neovascularization manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Choroidal Neovascularization This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Extreme Myopia, Malignant Myopic Degeneration).
Technology Analysis: Report covers specific technologies relevant to Choroidal Neovascularization. It assesses the current state, advancements, and potential future developments in Choroidal Neovascularization areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Choroidal Neovascularization market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Choroidal Neovascularization market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Choroidal Neovascularization product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Choroidal Neovascularization, with price, sales, revenue and global market share of Choroidal Neovascularization from 2019 to 2024.
Chapter 3, the Choroidal Neovascularization competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Choroidal Neovascularization breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Choroidal Neovascularization market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Choroidal Neovascularization.
Chapter 14 and 15, to describe Choroidal Neovascularization sales channel, distributors, customers, research findings and conclusion.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Choroidal Neovascularization industry chain, the market status of Extreme Myopia (Intravenous, Intravitreal), Malignant Myopic Degeneration (Intravenous, Intravitreal), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Choroidal Neovascularization.
Regionally, the report analyzes the Choroidal Neovascularization markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Choroidal Neovascularization market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Choroidal Neovascularization market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Choroidal Neovascularization industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Intravenous, Intravitreal).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Choroidal Neovascularization market.
Regional Analysis: The report involves examining the Choroidal Neovascularization market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Choroidal Neovascularization market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Choroidal Neovascularization:
Company Analysis: Report covers individual Choroidal Neovascularization manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Choroidal Neovascularization This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Extreme Myopia, Malignant Myopic Degeneration).
Technology Analysis: Report covers specific technologies relevant to Choroidal Neovascularization. It assesses the current state, advancements, and potential future developments in Choroidal Neovascularization areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Choroidal Neovascularization market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Choroidal Neovascularization market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Intravenous
- Intravitreal
- Extreme Myopia
- Malignant Myopic Degeneration
- Age-Related Developments
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Bayer AG
- QLT Inc.
- Sanwa Kagaku Kenkyusho Co. Ltd.
- Promedior Inc.
- Bausch Health
- Gilead Sciences Inc
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Choroidal Neovascularization product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Choroidal Neovascularization, with price, sales, revenue and global market share of Choroidal Neovascularization from 2019 to 2024.
Chapter 3, the Choroidal Neovascularization competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Choroidal Neovascularization breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Choroidal Neovascularization market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Choroidal Neovascularization.
Chapter 14 and 15, to describe Choroidal Neovascularization sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Choroidal Neovascularization Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Intravenous
1.3.3 Intravitreal
1.4 Market Analysis by Application
1.4.1 Overview: Global Choroidal Neovascularization Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Extreme Myopia
1.4.3 Malignant Myopic Degeneration
1.4.4 Age-Related Developments
1.5 Global Choroidal Neovascularization Market Size & Forecast
1.5.1 Global Choroidal Neovascularization Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Choroidal Neovascularization Sales Quantity (2019-2030)
1.5.3 Global Choroidal Neovascularization Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Choroidal Neovascularization Product and Services
2.1.4 Pfizer Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product and Services
2.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Choroidal Neovascularization Product and Services
2.3.4 Novartis AG Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Regeneron Pharmaceuticals Inc.
2.4.1 Regeneron Pharmaceuticals Inc. Details
2.4.2 Regeneron Pharmaceuticals Inc. Major Business
2.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product and Services
2.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Choroidal Neovascularization Product and Services
2.5.4 Bayer AG Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer AG Recent Developments/Updates
2.6 QLT Inc.
2.6.1 QLT Inc. Details
2.6.2 QLT Inc. Major Business
2.6.3 QLT Inc. Choroidal Neovascularization Product and Services
2.6.4 QLT Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 QLT Inc. Recent Developments/Updates
2.7 Sanwa Kagaku Kenkyusho Co. Ltd.
2.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Details
2.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Major Business
2.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product and Services
2.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
2.8 Promedior Inc.
2.8.1 Promedior Inc. Details
2.8.2 Promedior Inc. Major Business
2.8.3 Promedior Inc. Choroidal Neovascularization Product and Services
2.8.4 Promedior Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Promedior Inc. Recent Developments/Updates
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business
2.9.3 Bausch Health Choroidal Neovascularization Product and Services
2.9.4 Bausch Health Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bausch Health Recent Developments/Updates
2.10 Gilead Sciences Inc
2.10.1 Gilead Sciences Inc Details
2.10.2 Gilead Sciences Inc Major Business
2.10.3 Gilead Sciences Inc Choroidal Neovascularization Product and Services
2.10.4 Gilead Sciences Inc Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Gilead Sciences Inc Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHOROIDAL NEOVASCULARIZATION BY MANUFACTURER
3.1 Global Choroidal Neovascularization Sales Quantity by Manufacturer (2019-2024)
3.2 Global Choroidal Neovascularization Revenue by Manufacturer (2019-2024)
3.3 Global Choroidal Neovascularization Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Choroidal Neovascularization by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Choroidal Neovascularization Manufacturer Market Share in 2023
3.4.2 Top 6 Choroidal Neovascularization Manufacturer Market Share in 2023
3.5 Choroidal Neovascularization Market: Overall Company Footprint Analysis
3.5.1 Choroidal Neovascularization Market: Region Footprint
3.5.2 Choroidal Neovascularization Market: Company Product Type Footprint
3.5.3 Choroidal Neovascularization Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Choroidal Neovascularization Market Size by Region
4.1.1 Global Choroidal Neovascularization Sales Quantity by Region (2019-2030)
4.1.2 Global Choroidal Neovascularization Consumption Value by Region (2019-2030)
4.1.3 Global Choroidal Neovascularization Average Price by Region (2019-2030)
4.2 North America Choroidal Neovascularization Consumption Value (2019-2030)
4.3 Europe Choroidal Neovascularization Consumption Value (2019-2030)
4.4 Asia-Pacific Choroidal Neovascularization Consumption Value (2019-2030)
4.5 South America Choroidal Neovascularization Consumption Value (2019-2030)
4.6 Middle East and Africa Choroidal Neovascularization Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Choroidal Neovascularization Sales Quantity by Type (2019-2030)
5.2 Global Choroidal Neovascularization Consumption Value by Type (2019-2030)
5.3 Global Choroidal Neovascularization Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Choroidal Neovascularization Sales Quantity by Application (2019-2030)
6.2 Global Choroidal Neovascularization Consumption Value by Application (2019-2030)
6.3 Global Choroidal Neovascularization Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Choroidal Neovascularization Sales Quantity by Type (2019-2030)
7.2 North America Choroidal Neovascularization Sales Quantity by Application (2019-2030)
7.3 North America Choroidal Neovascularization Market Size by Country
7.3.1 North America Choroidal Neovascularization Sales Quantity by Country (2019-2030)
7.3.2 North America Choroidal Neovascularization Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Choroidal Neovascularization Sales Quantity by Type (2019-2030)
8.2 Europe Choroidal Neovascularization Sales Quantity by Application (2019-2030)
8.3 Europe Choroidal Neovascularization Market Size by Country
8.3.1 Europe Choroidal Neovascularization Sales Quantity by Country (2019-2030)
8.3.2 Europe Choroidal Neovascularization Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Choroidal Neovascularization Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Choroidal Neovascularization Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Choroidal Neovascularization Market Size by Region
9.3.1 Asia-Pacific Choroidal Neovascularization Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Choroidal Neovascularization Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Choroidal Neovascularization Sales Quantity by Type (2019-2030)
10.2 South America Choroidal Neovascularization Sales Quantity by Application (2019-2030)
10.3 South America Choroidal Neovascularization Market Size by Country
10.3.1 South America Choroidal Neovascularization Sales Quantity by Country (2019-2030)
10.3.2 South America Choroidal Neovascularization Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Choroidal Neovascularization Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Choroidal Neovascularization Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Choroidal Neovascularization Market Size by Country
11.3.1 Middle East & Africa Choroidal Neovascularization Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Choroidal Neovascularization Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Choroidal Neovascularization Market Drivers
12.2 Choroidal Neovascularization Market Restraints
12.3 Choroidal Neovascularization Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Choroidal Neovascularization and Key Manufacturers
13.2 Manufacturing Costs Percentage of Choroidal Neovascularization
13.3 Choroidal Neovascularization Production Process
13.4 Choroidal Neovascularization Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Choroidal Neovascularization Typical Distributors
14.3 Choroidal Neovascularization Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Choroidal Neovascularization
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Choroidal Neovascularization Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Intravenous
1.3.3 Intravitreal
1.4 Market Analysis by Application
1.4.1 Overview: Global Choroidal Neovascularization Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Extreme Myopia
1.4.3 Malignant Myopic Degeneration
1.4.4 Age-Related Developments
1.5 Global Choroidal Neovascularization Market Size & Forecast
1.5.1 Global Choroidal Neovascularization Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Choroidal Neovascularization Sales Quantity (2019-2030)
1.5.3 Global Choroidal Neovascularization Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Choroidal Neovascularization Product and Services
2.1.4 Pfizer Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 F. Hoffmann-La Roche Ltd.
2.2.1 F. Hoffmann-La Roche Ltd. Details
2.2.2 F. Hoffmann-La Roche Ltd. Major Business
2.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product and Services
2.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Choroidal Neovascularization Product and Services
2.3.4 Novartis AG Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Regeneron Pharmaceuticals Inc.
2.4.1 Regeneron Pharmaceuticals Inc. Details
2.4.2 Regeneron Pharmaceuticals Inc. Major Business
2.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product and Services
2.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Regeneron Pharmaceuticals Inc. Recent Developments/Updates
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Choroidal Neovascularization Product and Services
2.5.4 Bayer AG Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer AG Recent Developments/Updates
2.6 QLT Inc.
2.6.1 QLT Inc. Details
2.6.2 QLT Inc. Major Business
2.6.3 QLT Inc. Choroidal Neovascularization Product and Services
2.6.4 QLT Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 QLT Inc. Recent Developments/Updates
2.7 Sanwa Kagaku Kenkyusho Co. Ltd.
2.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Details
2.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Major Business
2.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product and Services
2.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
2.8 Promedior Inc.
2.8.1 Promedior Inc. Details
2.8.2 Promedior Inc. Major Business
2.8.3 Promedior Inc. Choroidal Neovascularization Product and Services
2.8.4 Promedior Inc. Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Promedior Inc. Recent Developments/Updates
2.9 Bausch Health
2.9.1 Bausch Health Details
2.9.2 Bausch Health Major Business
2.9.3 Bausch Health Choroidal Neovascularization Product and Services
2.9.4 Bausch Health Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Bausch Health Recent Developments/Updates
2.10 Gilead Sciences Inc
2.10.1 Gilead Sciences Inc Details
2.10.2 Gilead Sciences Inc Major Business
2.10.3 Gilead Sciences Inc Choroidal Neovascularization Product and Services
2.10.4 Gilead Sciences Inc Choroidal Neovascularization Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Gilead Sciences Inc Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CHOROIDAL NEOVASCULARIZATION BY MANUFACTURER
3.1 Global Choroidal Neovascularization Sales Quantity by Manufacturer (2019-2024)
3.2 Global Choroidal Neovascularization Revenue by Manufacturer (2019-2024)
3.3 Global Choroidal Neovascularization Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Choroidal Neovascularization by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Choroidal Neovascularization Manufacturer Market Share in 2023
3.4.2 Top 6 Choroidal Neovascularization Manufacturer Market Share in 2023
3.5 Choroidal Neovascularization Market: Overall Company Footprint Analysis
3.5.1 Choroidal Neovascularization Market: Region Footprint
3.5.2 Choroidal Neovascularization Market: Company Product Type Footprint
3.5.3 Choroidal Neovascularization Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Choroidal Neovascularization Market Size by Region
4.1.1 Global Choroidal Neovascularization Sales Quantity by Region (2019-2030)
4.1.2 Global Choroidal Neovascularization Consumption Value by Region (2019-2030)
4.1.3 Global Choroidal Neovascularization Average Price by Region (2019-2030)
4.2 North America Choroidal Neovascularization Consumption Value (2019-2030)
4.3 Europe Choroidal Neovascularization Consumption Value (2019-2030)
4.4 Asia-Pacific Choroidal Neovascularization Consumption Value (2019-2030)
4.5 South America Choroidal Neovascularization Consumption Value (2019-2030)
4.6 Middle East and Africa Choroidal Neovascularization Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Choroidal Neovascularization Sales Quantity by Type (2019-2030)
5.2 Global Choroidal Neovascularization Consumption Value by Type (2019-2030)
5.3 Global Choroidal Neovascularization Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Choroidal Neovascularization Sales Quantity by Application (2019-2030)
6.2 Global Choroidal Neovascularization Consumption Value by Application (2019-2030)
6.3 Global Choroidal Neovascularization Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Choroidal Neovascularization Sales Quantity by Type (2019-2030)
7.2 North America Choroidal Neovascularization Sales Quantity by Application (2019-2030)
7.3 North America Choroidal Neovascularization Market Size by Country
7.3.1 North America Choroidal Neovascularization Sales Quantity by Country (2019-2030)
7.3.2 North America Choroidal Neovascularization Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Choroidal Neovascularization Sales Quantity by Type (2019-2030)
8.2 Europe Choroidal Neovascularization Sales Quantity by Application (2019-2030)
8.3 Europe Choroidal Neovascularization Market Size by Country
8.3.1 Europe Choroidal Neovascularization Sales Quantity by Country (2019-2030)
8.3.2 Europe Choroidal Neovascularization Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Choroidal Neovascularization Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Choroidal Neovascularization Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Choroidal Neovascularization Market Size by Region
9.3.1 Asia-Pacific Choroidal Neovascularization Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Choroidal Neovascularization Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Choroidal Neovascularization Sales Quantity by Type (2019-2030)
10.2 South America Choroidal Neovascularization Sales Quantity by Application (2019-2030)
10.3 South America Choroidal Neovascularization Market Size by Country
10.3.1 South America Choroidal Neovascularization Sales Quantity by Country (2019-2030)
10.3.2 South America Choroidal Neovascularization Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Choroidal Neovascularization Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Choroidal Neovascularization Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Choroidal Neovascularization Market Size by Country
11.3.1 Middle East & Africa Choroidal Neovascularization Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Choroidal Neovascularization Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Choroidal Neovascularization Market Drivers
12.2 Choroidal Neovascularization Market Restraints
12.3 Choroidal Neovascularization Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Choroidal Neovascularization and Key Manufacturers
13.2 Manufacturing Costs Percentage of Choroidal Neovascularization
13.3 Choroidal Neovascularization Production Process
13.4 Choroidal Neovascularization Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Choroidal Neovascularization Typical Distributors
14.3 Choroidal Neovascularization Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Choroidal Neovascularization Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Choroidal Neovascularization Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Choroidal Neovascularization Product and Services
Table 6. Pfizer Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. F. Hoffmann-La Roche Ltd. Major Business
Table 10. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product and Services
Table 11. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Choroidal Neovascularization Product and Services
Table 16. Novartis AG Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Regeneron Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Regeneron Pharmaceuticals Inc. Major Business
Table 20. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product and Services
Table 21. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Regeneron Pharmaceuticals Inc. Recent Developments/Updates
Table 23. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG Major Business
Table 25. Bayer AG Choroidal Neovascularization Product and Services
Table 26. Bayer AG Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bayer AG Recent Developments/Updates
Table 28. QLT Inc. Basic Information, Manufacturing Base and Competitors
Table 29. QLT Inc. Major Business
Table 30. QLT Inc. Choroidal Neovascularization Product and Services
Table 31. QLT Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. QLT Inc. Recent Developments/Updates
Table 33. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Sanwa Kagaku Kenkyusho Co. Ltd. Major Business
Table 35. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product and Services
Table 36. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
Table 38. Promedior Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Promedior Inc. Major Business
Table 40. Promedior Inc. Choroidal Neovascularization Product and Services
Table 41. Promedior Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Promedior Inc. Recent Developments/Updates
Table 43. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 44. Bausch Health Major Business
Table 45. Bausch Health Choroidal Neovascularization Product and Services
Table 46. Bausch Health Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bausch Health Recent Developments/Updates
Table 48. Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 49. Gilead Sciences Inc Major Business
Table 50. Gilead Sciences Inc Choroidal Neovascularization Product and Services
Table 51. Gilead Sciences Inc Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Gilead Sciences Inc Recent Developments/Updates
Table 53. Global Choroidal Neovascularization Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Choroidal Neovascularization Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Choroidal Neovascularization Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Choroidal Neovascularization, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Choroidal Neovascularization Production Site of Key Manufacturer
Table 58. Choroidal Neovascularization Market: Company Product Type Footprint
Table 59. Choroidal Neovascularization Market: Company Product Application Footprint
Table 60. Choroidal Neovascularization New Market Entrants and Barriers to Market Entry
Table 61. Choroidal Neovascularization Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Choroidal Neovascularization Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Choroidal Neovascularization Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Choroidal Neovascularization Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Choroidal Neovascularization Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Choroidal Neovascularization Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Choroidal Neovascularization Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Choroidal Neovascularization Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Choroidal Neovascularization Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Choroidal Neovascularization Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Choroidal Neovascularization Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Choroidal Neovascularization Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Choroidal Neovascularization Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Choroidal Neovascularization Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Choroidal Neovascularization Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Choroidal Neovascularization Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Choroidal Neovascularization Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Choroidal Neovascularization Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Choroidal Neovascularization Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Choroidal Neovascularization Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Choroidal Neovascularization Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Choroidal Neovascularization Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Choroidal Neovascularization Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Choroidal Neovascularization Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Choroidal Neovascularization Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Choroidal Neovascularization Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Choroidal Neovascularization Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Choroidal Neovascularization Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Choroidal Neovascularization Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Choroidal Neovascularization Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Choroidal Neovascularization Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Choroidal Neovascularization Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Choroidal Neovascularization Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Choroidal Neovascularization Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Choroidal Neovascularization Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Choroidal Neovascularization Raw Material
Table 121. Key Manufacturers of Choroidal Neovascularization Raw Materials
Table 122. Choroidal Neovascularization Typical Distributors
Table 123. Choroidal Neovascularization Typical Customers
Table 1. Global Choroidal Neovascularization Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Choroidal Neovascularization Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Choroidal Neovascularization Product and Services
Table 6. Pfizer Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. F. Hoffmann-La Roche Ltd. Major Business
Table 10. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product and Services
Table 11. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Choroidal Neovascularization Product and Services
Table 16. Novartis AG Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Regeneron Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Regeneron Pharmaceuticals Inc. Major Business
Table 20. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product and Services
Table 21. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Regeneron Pharmaceuticals Inc. Recent Developments/Updates
Table 23. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG Major Business
Table 25. Bayer AG Choroidal Neovascularization Product and Services
Table 26. Bayer AG Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bayer AG Recent Developments/Updates
Table 28. QLT Inc. Basic Information, Manufacturing Base and Competitors
Table 29. QLT Inc. Major Business
Table 30. QLT Inc. Choroidal Neovascularization Product and Services
Table 31. QLT Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. QLT Inc. Recent Developments/Updates
Table 33. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Sanwa Kagaku Kenkyusho Co. Ltd. Major Business
Table 35. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product and Services
Table 36. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments/Updates
Table 38. Promedior Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Promedior Inc. Major Business
Table 40. Promedior Inc. Choroidal Neovascularization Product and Services
Table 41. Promedior Inc. Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Promedior Inc. Recent Developments/Updates
Table 43. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 44. Bausch Health Major Business
Table 45. Bausch Health Choroidal Neovascularization Product and Services
Table 46. Bausch Health Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Bausch Health Recent Developments/Updates
Table 48. Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 49. Gilead Sciences Inc Major Business
Table 50. Gilead Sciences Inc Choroidal Neovascularization Product and Services
Table 51. Gilead Sciences Inc Choroidal Neovascularization Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Gilead Sciences Inc Recent Developments/Updates
Table 53. Global Choroidal Neovascularization Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Choroidal Neovascularization Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Choroidal Neovascularization Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Choroidal Neovascularization, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Choroidal Neovascularization Production Site of Key Manufacturer
Table 58. Choroidal Neovascularization Market: Company Product Type Footprint
Table 59. Choroidal Neovascularization Market: Company Product Application Footprint
Table 60. Choroidal Neovascularization New Market Entrants and Barriers to Market Entry
Table 61. Choroidal Neovascularization Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Choroidal Neovascularization Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Choroidal Neovascularization Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Choroidal Neovascularization Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Choroidal Neovascularization Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Choroidal Neovascularization Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Choroidal Neovascularization Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Choroidal Neovascularization Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Choroidal Neovascularization Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Choroidal Neovascularization Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Choroidal Neovascularization Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Choroidal Neovascularization Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Choroidal Neovascularization Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Choroidal Neovascularization Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Choroidal Neovascularization Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Choroidal Neovascularization Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Choroidal Neovascularization Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Choroidal Neovascularization Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Choroidal Neovascularization Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Choroidal Neovascularization Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Choroidal Neovascularization Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Choroidal Neovascularization Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Choroidal Neovascularization Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Choroidal Neovascularization Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Choroidal Neovascularization Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Choroidal Neovascularization Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Choroidal Neovascularization Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Choroidal Neovascularization Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Choroidal Neovascularization Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Choroidal Neovascularization Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Choroidal Neovascularization Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Choroidal Neovascularization Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Choroidal Neovascularization Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Choroidal Neovascularization Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Choroidal Neovascularization Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Choroidal Neovascularization Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Choroidal Neovascularization Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Choroidal Neovascularization Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Choroidal Neovascularization Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Choroidal Neovascularization Raw Material
Table 121. Key Manufacturers of Choroidal Neovascularization Raw Materials
Table 122. Choroidal Neovascularization Typical Distributors
Table 123. Choroidal Neovascularization Typical Customers
LIST OF FIGURES
Figure 1. Choroidal Neovascularization Picture
Figure 2. Global Choroidal Neovascularization Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Choroidal Neovascularization Consumption Value Market Share by Type in 2023
Figure 4. Intravenous Examples
Figure 5. Intravitreal Examples
Figure 6. Global Choroidal Neovascularization Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Choroidal Neovascularization Consumption Value Market Share by Application in 2023
Figure 8. Extreme Myopia Examples
Figure 9. Malignant Myopic Degeneration Examples
Figure 10. Age-Related Developments Examples
Figure 11. Global Choroidal Neovascularization Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Choroidal Neovascularization Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Choroidal Neovascularization Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Choroidal Neovascularization Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Choroidal Neovascularization Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Choroidal Neovascularization Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Choroidal Neovascularization by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Choroidal Neovascularization Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Choroidal Neovascularization Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Choroidal Neovascularization Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Choroidal Neovascularization Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Choroidal Neovascularization Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Choroidal Neovascularization Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Choroidal Neovascularization Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Choroidal Neovascularization Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Choroidal Neovascularization Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Choroidal Neovascularization Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Choroidal Neovascularization Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Choroidal Neovascularization Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Choroidal Neovascularization Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Choroidal Neovascularization Consumption Value Market Share by Region (2019-2030)
Figure 53. China Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Choroidal Neovascularization Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Choroidal Neovascularization Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Choroidal Neovascularization Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Choroidal Neovascularization Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Choroidal Neovascularization Market Drivers
Figure 74. Choroidal Neovascularization Market Restraints
Figure 75. Choroidal Neovascularization Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Choroidal Neovascularization in 2023
Figure 78. Manufacturing Process Analysis of Choroidal Neovascularization
Figure 79. Choroidal Neovascularization Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Choroidal Neovascularization Picture
Figure 2. Global Choroidal Neovascularization Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Choroidal Neovascularization Consumption Value Market Share by Type in 2023
Figure 4. Intravenous Examples
Figure 5. Intravitreal Examples
Figure 6. Global Choroidal Neovascularization Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Choroidal Neovascularization Consumption Value Market Share by Application in 2023
Figure 8. Extreme Myopia Examples
Figure 9. Malignant Myopic Degeneration Examples
Figure 10. Age-Related Developments Examples
Figure 11. Global Choroidal Neovascularization Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Choroidal Neovascularization Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Choroidal Neovascularization Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Choroidal Neovascularization Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Choroidal Neovascularization Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Choroidal Neovascularization Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Choroidal Neovascularization by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Choroidal Neovascularization Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Choroidal Neovascularization Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Choroidal Neovascularization Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Choroidal Neovascularization Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Choroidal Neovascularization Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Choroidal Neovascularization Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Choroidal Neovascularization Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Choroidal Neovascularization Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Choroidal Neovascularization Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Choroidal Neovascularization Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Choroidal Neovascularization Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Choroidal Neovascularization Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Choroidal Neovascularization Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Choroidal Neovascularization Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Choroidal Neovascularization Consumption Value Market Share by Region (2019-2030)
Figure 53. China Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Choroidal Neovascularization Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Choroidal Neovascularization Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Choroidal Neovascularization Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Choroidal Neovascularization Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Choroidal Neovascularization Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Choroidal Neovascularization Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Choroidal Neovascularization Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Choroidal Neovascularization Market Drivers
Figure 74. Choroidal Neovascularization Market Restraints
Figure 75. Choroidal Neovascularization Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Choroidal Neovascularization in 2023
Figure 78. Manufacturing Process Analysis of Choroidal Neovascularization
Figure 79. Choroidal Neovascularization Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
